lecture 4 - drug metabolism Flashcards
importance of understanding biotransformation
- major route of drug elimination
- often activates/inactivates drugs
- may produce toxic products
- source of between patient variability
- explains many drug-drug interactions
phase 1 of biotransformation
metabolism
oxygen inserted into molecules
major enzyme systems = cytochrome p450 (CYP)
phase 2 of biotransformation
conjugation, addition of another alkyl group
typically involves sugars, acetates, sulfates being added
major enzyme systems, transferases
describe cytochrome P450
- found in gut wall and liver
- > 70% of drugs metabolized by CYPs
- contains Heme
CYP2E1
marker drug = ethanol
clinically relevant substrate = analgesic substrate
drug interaction = ethanol
CYP1A2
marker drug = theophylline
clinically relevant substrate = bronchodilator
drug interaction =
tobacco, green veges, BBQ (inducer)
cimetidine (inhibitor)
CYP2C9
marker drug = s-warfarin
clinically relevant = anticoagulant
adverse event risk = lower dose & increased bleeding
CYP2C19
marker drug = mephenytoin
clinically relevant = acid-pump inhibitor (omeprazole)
omeprazole
used for GORD, cures 86% in poor metabolizers
inhibits CYP2C19
side effect = it decreases effectiveness of clopidogrel when combined with omeprazole
CYP3A4
marker drug = simvastatin
clinically relevant substrates =
- HMG-CoA inhibitor - protease inhibitor - immunosuppressant
drug interaction
- ketoconazole, grapefruit juice (inhibitor) - St johns Wort (inducor)
CYP activity
induction
- increased activity
- many substances can induce (e.g. tobacco & CYP1A2)
inhibition
- decreased activity
- usually competitive (e.g. grapefruit & CYP3A4 in gut)
cytochrome P450 inhibitor
reduces the metabolism of the substrate, thereby increasing its concentration and physiologic effect.